FHTX – foghorn therapeutics inc. (US:NASDAQ)
Stock Stats
News
Foghorn Therapeutics (NASDAQ:FHTX) was upgraded by analysts at Wall Stre
Foghorn Therapeutics (NASDAQ:FHTX) was upgraded by analysts at BTIG Research to a "strong-buy" rating.
Foghorn Therapeutics (NASDAQ:FHTX) is now covered by analysts at BTIG Research. They set a "buy" rating on the stock.
Foghorn Therapeutics (NASDAQ:FHTX) was downgraded by analysts at Wall St
Foghorn Therapeutics (NASDAQ:FHTX) was given a new $12.00 price target on by analysts at Stifel Nicolaus.
Form 8-K Foghorn Therapeutics For: Dec 03
Form 4 Foghorn Therapeutics For: Nov 14 Filed by: Humer Kristian
Form 8-K Foghorn Therapeutics For: Nov 07
Form 10-Q Foghorn Therapeutics For: Sep 30
Form 8-K Foghorn Therapeutics For: Nov 05
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.